SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001520138-22-000313
Filing Date
2022-07-18
Accepted
2022-07-18 17:10:30
Documents
14
Period of Report
2022-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20220715_8ka1.htm   iXBRL 8-K/A 29374
2 EXHIBIT 4.1 bivi-20220715_8ka1ex4z1.htm EX-4.1 109453
3 EXHIBIT 10.1 bivi-20220715_8ka1ex10z1.htm EX-10.1 260286
  Complete submission text file 0001520138-22-000313.txt   657139

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bivi-20220715.xsd EX-101.SCH 2980
5 XBRL LABEL FILE bivi-20220715_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bivi-20220715_pre.xml EX-101.PRE 22373
8 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20220715_8ka1_htm.xml XML 4258
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-39015 | Film No.: 221089807
SIC: 2834 Pharmaceutical Preparations